Jonathan Baell

Executive Director, Early Leads Chemistry

Jonathan Baell PhD is a highly experienced and well-credentialed medicinal chemist, & Executive Director of Early Leads Chemistry at Lyterian Therapeutics (San Francisco). He is a Distinguished Visiting Professor at Nanjing Tech University, and a sought-after Medicinal Chemistry Consultant. From 2012-2022, he has been Director, Australian Translational Medicinal Chemistry Facility, Monash University. He has more than 15 years of experience in medicinal chemistry-led drug discovery and development at the public-private interface, with more than 150 publications and 9000 citations, including first author Nature 2018, and more than 80 granted patents, outcomes for which include licencing deals and drug candidates progressing to Phase II clinical trials.

Talks About
#chemistry #medicinal

Preferred Locations
#Northamerica